Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia.

Arto Puranen Marjaana Koponen Antti Tanskanen Jari Tiihonen Heidi Taipale

Published in: European journal of clinical pharmacology (2020)

Clinical guidelines rarely recommend the use of AD or MS as adjunctive treatment in persons with schizophrenia. However, this population is often treated with AD or MS. More studies are needed to evaluate benefits and risks of these medications as adjunctive treatment of schizophrenia.

Keyphrases

bipolar disorder
major depressive disorder
mass spectrometry
multiple sclerosis
ms ms
clinical practice
combination therapy
human health